Search results

Order by most recent / most popular / relevance

Results: 1-5 of 5

Compulsory patent licensing in China

Morrison & Foerster LLP
-
China
-
January 16 2013

Recent years have seen a growing trend among developing countries such as Thailand, Malaysia, Indonesia, India, and Brazil of enacting and utilizing

Patent term extensions and regulatory exclusivities for pharmaceuticals in Asia and South America

Morrison & Foerster LLP
-
Argentina, Brazil, Chile, China, Hong Kong, Japan, Malaysia, Mexico, Philippines, South Korea, Thailand, USA, Vietnam
-
June 27 2012

Patent protection for pharmaceutical products has an impact on the pharmaceutical market and innovation

Key regulatory development

Morrison & Foerster LLP
-
China, USA
-
December 15 2011

On November 30, the United States Patent and Trademark Office (USPTO) announced a Paris Route and PCT Patent Prosecution Highway (PPH) pilot program with China’s State Intellectual Property Office (SIPO) that became effective on December 1, 2011

Implications of the Leahy-Smith America Invents Act for Chinese life science companies

Morrison & Foerster LLP
-
China, USA
-
December 15 2011

The Leahy-Smith America Invents Act (AIA) was signed into law by President Barack Obama on September 16, 2011

Patent procurement and enforcement in China: a field guide

Morrison & Foerster LLP
-
China
-
November 18 2011

It is difficult to read the world news today and not come across an article (or three) that discusses the increasingly important role that China plays in the world’s economy

Search results

Compulsory patent licensing in China

Patent term extensions and regulatory exclusivities for pharmaceuticals in Asia and South America

Key regulatory development

Implications of the Leahy-Smith America Invents Act for Chinese life science companies

Patent procurement and enforcement in China: a field guide

Current Search

Suggested Facets

Author

Jurisdiction